# Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine

> **NCT03489889** · NA · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 30 (actual)

## Conditions studied

- Ursodeoxycholic Acid
- Primary Biliary Cirrhosis

## Interventions

- **DRUG:** Ursodeoxycholic Acid 300mg tablet
- **DRUG:** Ursodeoxycholic Acid 300mg capsule

## Key facts

- **NCT ID:** NCT03489889
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03489889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03489889, "Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03489889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*